Literature DB >> 9125249

A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states.

H Brahms1, V A Raker, W J van Venrooij, R Lührmann.   

Abstract

OBJECTIVE: To determine whether the E, F, and G Sm proteins present antigenic determinants recognized by systemic lupus erythematosus (SLE) patient sera, and if so, whether the antigenicity depends on the native conformations of the polypeptides and/or is E-F-G complex restricted.
METHODS: Radioimmunoprecipitation, epitope tagging, expression polymerase chain reaction, in vitro translation, in vitro reconstitution, and immunoblotting.
RESULTS: Most of the anti-Sm SLE patient sera tested reacted with one or more of the E, F, and G proteins in immunoprecipitation studies but not on immunoblots. All sera, however, highly efficiently immunoprecipitated the E-F-G complex. This complex recognition was detected exclusively in anti-Sm patient sera but not in patient sera with other serotypes.
CONCLUSION: We demonstrate the presence of a novel and abundant anti-Sm autoantibody class in SLE patient sera which exclusively or predominantly recognizes conformational Sm epitopes present on the E-F-G complex but not on the denatured proteins. This complex recognition is highly specific for sera of the anti-Sm serotype and may be relevant for clinical diagnosis as well as for understanding the etiology of anti-Sm autoantibody production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125249     DOI: 10.1002/art.1780400412

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin.

Authors:  J Salgado-Garrido; E Bragado-Nilsson; S Kandels-Lewis; B Séraphin
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein.

Authors:  H Brahms; L Meheus; V de Brabandere; U Fischer; R Lührmann
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

3.  Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay.

Authors:  M Mahler; L M Stinton; M J Fritzler
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

4.  A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.

Authors:  G Riemekasten; J Marell; G Trebeljahr; R Klein; G Hausdorf; T Häupl; J Schneider-Mergener; G R Burmester; F Hiepe
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

5.  The human Pat1b protein: a novel mRNA deadenylation factor identified by a new immunoprecipitation technique.

Authors:  Antonio Totaro; Fabrizio Renzi; Giorgio La Fata; Claudia Mattioli; Monika Raabe; Henning Urlaub; Tilmann Achsel
Journal:  Nucleic Acids Res       Date:  2010-09-17       Impact factor: 16.971

6.  Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.

Authors:  Michael Mahler; Marvin J Fritzler; Martin Blüthner
Journal:  Arthritis Res Ther       Date:  2004-11-10       Impact factor: 5.156

7.  Link-Polymorphism of 5-HTT Promoter Region Is Associated with Autoantibodies in Patients with Systemic Lupus Erythematosus.

Authors:  Shu Li; Shuang Liu; Fan Chen; Yuqi Cheng; Ru Bai; Aiyun Lai; Zhaoping Lu; Jian Xu
Journal:  J Immunol Res       Date:  2016-10-13       Impact factor: 4.818

8.  Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus.

Authors:  Michael Mahler; Aderajew Waka; F Hiepe; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease.

Authors:  Daniëlle Hof; Kalok Cheung; Dirk-Jan R A M de Rooij; Frank H van den Hoogen; Ger J M Pruijn; Walther J van Venrooij; Jos M H Raats
Journal:  Arthritis Res Ther       Date:  2005-01-11       Impact factor: 5.156

Review 10.  Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Authors:  Mandy Sowa; Rico Hiemann; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.